全文获取类型
收费全文 | 1408篇 |
免费 | 170篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 77篇 |
妇产科学 | 17篇 |
基础医学 | 291篇 |
口腔科学 | 9篇 |
临床医学 | 128篇 |
内科学 | 402篇 |
皮肤病学 | 30篇 |
神经病学 | 133篇 |
特种医学 | 52篇 |
外科学 | 127篇 |
综合类 | 36篇 |
预防医学 | 115篇 |
眼科学 | 24篇 |
药学 | 80篇 |
中国医学 | 1篇 |
肿瘤学 | 35篇 |
出版年
2022年 | 10篇 |
2021年 | 31篇 |
2020年 | 12篇 |
2019年 | 16篇 |
2018年 | 22篇 |
2017年 | 14篇 |
2016年 | 18篇 |
2015年 | 20篇 |
2014年 | 22篇 |
2013年 | 52篇 |
2012年 | 66篇 |
2011年 | 78篇 |
2010年 | 33篇 |
2009年 | 49篇 |
2008年 | 53篇 |
2007年 | 71篇 |
2006年 | 64篇 |
2005年 | 50篇 |
2004年 | 67篇 |
2003年 | 59篇 |
2002年 | 55篇 |
2001年 | 51篇 |
2000年 | 40篇 |
1999年 | 40篇 |
1998年 | 24篇 |
1997年 | 22篇 |
1996年 | 26篇 |
1995年 | 15篇 |
1994年 | 28篇 |
1993年 | 22篇 |
1992年 | 32篇 |
1991年 | 20篇 |
1990年 | 31篇 |
1989年 | 31篇 |
1988年 | 18篇 |
1987年 | 22篇 |
1986年 | 24篇 |
1985年 | 27篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1982年 | 10篇 |
1981年 | 13篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1978年 | 16篇 |
1977年 | 21篇 |
1976年 | 20篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1971年 | 13篇 |
排序方式: 共有1580条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
LEE JS IM HH JUNG Y JUNG IS JANG JY CHUN YK CHO YD KIM JO CHO JY KIM YS SHIM CS & KIM BS 《Neurogastroenterology and motility》2006,18(6):493-494
Background: Recent development of extracorporeal magnetic stimulation (ECMS) which uses current‐changing magnetic fields allows the induction of electrical stimulation in the desired deep tissue. Recent study showed the sacral nerve stimulation reduces corticoanal excitability that may play a functional role in anal continence mechanisms. Preliminary study shows that ECMS of sacral nerve can modify pelvic floor function and expel rectal balloon in patients with pelvic floor dyssynergia (PFD). Aims: To evaluate the effect of ECMS compared with biofeedback therapy (BF) in patients with PFD. Methods and Materials: Thirty‐eight patients who fulfilled Rome II criteria for PFD by colon transit time and anorectal function tests, were randomly treated with 8 sessions of ECMS (2/weeks; n = 19) at prone position or BF (2/weeks; n = 19) at sitting position. Stimulation parameters were set at 50–80% of maximum intensity, 10 and 50 Hz frequency, 3 s burst length with 3 and 6 s off using arm‐typed stimulator (BioCom‐1000, Mcube Co., Korea). Symptom scores for constipation with/without anorectal function test were repeatedly measured after each treatment. Response was defined as 50% or more decreased symptom score after treatment (partial response: 30–50%, poor: <30%). Results: Fifteen patients (age 49.1 ± 13.4 years, mean ± SD; 4 men) completed 8 session of BF and 14 patients (54.5 ± 17.6 years, 3 men) completed 8 session of ECMS. Four patients of BF group discontinued treatment due to unsatisfactory therapeutic effect (n = 1) and withdrew consent (n = 3) and 5 patients of ECMS group discontinued treatment because of same reasons (n = 1, 4). Total symptom scores were significantly decreased after treatment of 8 session in both treatment groups (13.4 ± 6.6 vs. 4.3 ± 4.0 for BF, p = 0.009; 14.9 ± 5.6 vs. 3.4 ± 4.0 for ECMS, p < 0.001). Bowel movements per week were also significantly increased after treatment in both groups (median 2 vs. 7 for BF, p = 0.035; median 2 vs. 7 for ECMS, p = 0.008). Thirteen out of 15 patients showed response in BF group and 12 out of 14 showed good response in ECMS group. No adverse effects in both groups. Conclusions: ECMS is as effective as BF for the treatment of PFD. Long‐term effect of ECMS for the patients with pelvic floor dyssynergia need to be evaluated in the near future. 相似文献
5.
6.
The vascularity of 49 renal masses (26 malignant and 23 benign lesions) was investigated with duplex Doppler ultrasound. Doppler signals obtained at the margins of renal masses were defined as "tumor signals" when the Doppler-shifted frequency of the lesion exceeded the frequency shift in the ipsilateral main renal artery. These exceeded 2.5 kHz with a 3-MHz insonating frequency. Among the 26 renal masses that subsequently proved to be malignant, tumor signals were obtained in 15 of 18 (83%) untreated renal cell carcinomas, in three of four Wilms tumors, and in two patients with metastases to the kidney, but not in the one patient with lymphoma. None of the 23 benign renal masses demonstrated tumor signals. Tumor vascularity in malignant lesions gives rise to abnormal, high-velocity, Doppler-shifted signals that can help in the differential diagnosis of renal masses. 相似文献
7.
The clinical history and histological features of seven cases of granulomatous mastitis are presented. The lesion occurs in young parous women as a tender extra-areolar breast lump. Histologically, non-caseating discrete granulomas are present, confined to breast lobules with, in three cases, coalescence of the granulomas and microabscess formation. Pathogenesis of the changes is discussed. It is thought that granulomatous mastitis is an entity morphologically distinct from duct ectasia/plasma cell mastitis and the commoner forms of granulomatous breast diseases. 相似文献
8.
TAP genes and immunity 总被引:4,自引:0,他引:4
The transporter associated with antigen processing (TAP) is a member of the ATP-binding cassette transporter family that specializes in delivering cytosolic peptides to class I molecules in the endoplasmic reticulum. The TAP is a major target of genetic alteration in tumours and disruption by viral inhibitors. In some species, TAP genes have co-evolved with MHC class I molecules to deliver peptides that are customised for particular alleles. In humans, MHC class I polymorphism determines the level of tapasin-mediated association with TAP and subsequent peptide optimisation within the peptide-loading complex (PLC). MHC class I molecules that still load peptides without complexing to the TAP might be more resistant to viral interference of the PLC and less sensitive to competition for TAP by other class I allotypes. 相似文献
9.
Sarah Curran Shaun Purcell Ian Craig Philip Asherson Pak Sham 《American journal of medical genetics. Part B, Neuropsychiatric genetics》2005,(1):42-47
Molecular studies of attention deficit hyperactivity disorder (ADHD) have identified susceptibility genes for the categorically diagnosed disorder using operational diagnostic criteria. Here, we take a QTL approach to mapping genes for ADHD using a composite continuous index of ADHD behavior in a large epidemiological sample. Previous studies of clinical ADHD suggest that two functional polymorphisms in the serotonin transporter gene (SLC6A4), one in the 5'-regulatory region of the gene (5-HTTLPR) and the other a VNTR (5-HTTVNTR) in the second intron, as well as a single nucleotide polymorphism in the 3'-untranslated region (3'-UTR SNP), may be associated with the disorder. Here, we investigate these polymorphisms as well as an additional ten SNPs spread across the gene. We found significant association with the long (L) allele of the 5-HTTLPR; P = 0.019, but neither the 5-HTTVNTR nor the 3'-UTR SNP were significantly associated. Significant associations (P < 0.05) were found for a further 5 the 10 other markers tested. We found evidence for two haplotype blocks spanning the region. We found strong evidence for association with the first haplotype block (comprised of four markers), with the significance of a combined primary and secondary test of association reaching an empirical P value = 0.0054 for the global test and an empirical P value = 0.00081 for the largest local test. Thus, we show here that SLC6A4, which has a major influence on brain serotonin availability, may be a QTL for ADHD. 相似文献
10.
IM Hann 《Journal of clinical pathology》1989,42(2):221-222